Protein discovery may help solve prostate cancer medicine resistance
Researchers discovered that a receptor protein called CHRM1 plays an important role in prostate cancer cells' resistance to docetaxel, a routinely used chemotherapeutic treatment to treat advanced cancer that has progressed beyond the prostate. Read further on Dynamite News:
Dynamite News ·